Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease

Won Ho Kim, Donghoon Choi, Jung Sun Kim, Young Guk Ko, Yangsoo Jang, Won Heum Shim

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Purpose: To compare long-term outcomes of endovascular and surgical treatment of arterial aneurysms in patients with vasculo-Behçet disease (VBD). Methods: The medical records of 912 patients with Behçet disease who were seen between May 1995 and January 2007 were reviewed. Among them, 34 (3.7%) patients with 39 non-cerebral aneurysmal lesions were diagnosed with VBD. Between February 1998 and November 2006, 16 VBD patients (14 men; mean age 39.2±9.2 years, range 25-63) were treated for 20 arterial aneurysms with an endovascular technique (stent-graft and/or coil embolization). All patients received immunosuppressive therapy (prednisolone 60 mg/d) before endovascular therapy to induce remission. From February 1993 to January 2007, 8 arterial aneurysms in 7 patients (all men; mean age 33.0±7.9 years, range 25-51) were treated with surgical graft interposition over 31.5±23.2 months. Results: The endovascular procedure was successful in all lesions. The mean follow-up was 47.6±41.8 months, during which 4 complications in 3 patients (3/16, 18.8%) occurred (2 occluded stent-grafts and 2 access site pseudoaneurysm). There were no deaths. The cumulative primary patency rate in the endovascular group was 89% at 24 months. In the 7 patients undergoing graft interposition for 8 arterial aneurysms, 3 (42.9%) events occurred in follow-up: 2 recurrent pseudoaneurysms and 1 aneurysm-related death. Conclusion: In Behçet disease, aneurysm treatment is performed whenever possible because of the high risk of rupture. Endovascular treatment of arterial aneurysms was effective and safe, with an acceptable vascular complication rate and excellent patency of the treated site.

Original languageEnglish
Pages (from-to)631-636
Number of pages6
JournalJournal of Endovascular Therapy
Volume16
Issue number5
DOIs
Publication statusPublished - 2009 Dec 18

Fingerprint

Aneurysm
Safety
Transplants
Endovascular Procedures
False Aneurysm
Therapeutics
Stents
Immunosuppressive Agents
Prednisolone
Medical Records
Blood Vessels
Rupture

All Science Journal Classification (ASJC) codes

  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

@article{f53e2abd7da041e0b793cfeddce093b7,
title = "Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Beh{\cc}et disease",
abstract = "Purpose: To compare long-term outcomes of endovascular and surgical treatment of arterial aneurysms in patients with vasculo-Beh{\cc}et disease (VBD). Methods: The medical records of 912 patients with Beh{\cc}et disease who were seen between May 1995 and January 2007 were reviewed. Among them, 34 (3.7{\%}) patients with 39 non-cerebral aneurysmal lesions were diagnosed with VBD. Between February 1998 and November 2006, 16 VBD patients (14 men; mean age 39.2±9.2 years, range 25-63) were treated for 20 arterial aneurysms with an endovascular technique (stent-graft and/or coil embolization). All patients received immunosuppressive therapy (prednisolone 60 mg/d) before endovascular therapy to induce remission. From February 1993 to January 2007, 8 arterial aneurysms in 7 patients (all men; mean age 33.0±7.9 years, range 25-51) were treated with surgical graft interposition over 31.5±23.2 months. Results: The endovascular procedure was successful in all lesions. The mean follow-up was 47.6±41.8 months, during which 4 complications in 3 patients (3/16, 18.8{\%}) occurred (2 occluded stent-grafts and 2 access site pseudoaneurysm). There were no deaths. The cumulative primary patency rate in the endovascular group was 89{\%} at 24 months. In the 7 patients undergoing graft interposition for 8 arterial aneurysms, 3 (42.9{\%}) events occurred in follow-up: 2 recurrent pseudoaneurysms and 1 aneurysm-related death. Conclusion: In Beh{\cc}et disease, aneurysm treatment is performed whenever possible because of the high risk of rupture. Endovascular treatment of arterial aneurysms was effective and safe, with an acceptable vascular complication rate and excellent patency of the treated site.",
author = "Kim, {Won Ho} and Donghoon Choi and Kim, {Jung Sun} and Ko, {Young Guk} and Yangsoo Jang and Shim, {Won Heum}",
year = "2009",
month = "12",
day = "18",
doi = "10.1583/09-2812.1",
language = "English",
volume = "16",
pages = "631--636",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "5",

}

Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease. / Kim, Won Ho; Choi, Donghoon; Kim, Jung Sun; Ko, Young Guk; Jang, Yangsoo; Shim, Won Heum.

In: Journal of Endovascular Therapy, Vol. 16, No. 5, 18.12.2009, p. 631-636.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease

AU - Kim, Won Ho

AU - Choi, Donghoon

AU - Kim, Jung Sun

AU - Ko, Young Guk

AU - Jang, Yangsoo

AU - Shim, Won Heum

PY - 2009/12/18

Y1 - 2009/12/18

N2 - Purpose: To compare long-term outcomes of endovascular and surgical treatment of arterial aneurysms in patients with vasculo-Behçet disease (VBD). Methods: The medical records of 912 patients with Behçet disease who were seen between May 1995 and January 2007 were reviewed. Among them, 34 (3.7%) patients with 39 non-cerebral aneurysmal lesions were diagnosed with VBD. Between February 1998 and November 2006, 16 VBD patients (14 men; mean age 39.2±9.2 years, range 25-63) were treated for 20 arterial aneurysms with an endovascular technique (stent-graft and/or coil embolization). All patients received immunosuppressive therapy (prednisolone 60 mg/d) before endovascular therapy to induce remission. From February 1993 to January 2007, 8 arterial aneurysms in 7 patients (all men; mean age 33.0±7.9 years, range 25-51) were treated with surgical graft interposition over 31.5±23.2 months. Results: The endovascular procedure was successful in all lesions. The mean follow-up was 47.6±41.8 months, during which 4 complications in 3 patients (3/16, 18.8%) occurred (2 occluded stent-grafts and 2 access site pseudoaneurysm). There were no deaths. The cumulative primary patency rate in the endovascular group was 89% at 24 months. In the 7 patients undergoing graft interposition for 8 arterial aneurysms, 3 (42.9%) events occurred in follow-up: 2 recurrent pseudoaneurysms and 1 aneurysm-related death. Conclusion: In Behçet disease, aneurysm treatment is performed whenever possible because of the high risk of rupture. Endovascular treatment of arterial aneurysms was effective and safe, with an acceptable vascular complication rate and excellent patency of the treated site.

AB - Purpose: To compare long-term outcomes of endovascular and surgical treatment of arterial aneurysms in patients with vasculo-Behçet disease (VBD). Methods: The medical records of 912 patients with Behçet disease who were seen between May 1995 and January 2007 were reviewed. Among them, 34 (3.7%) patients with 39 non-cerebral aneurysmal lesions were diagnosed with VBD. Between February 1998 and November 2006, 16 VBD patients (14 men; mean age 39.2±9.2 years, range 25-63) were treated for 20 arterial aneurysms with an endovascular technique (stent-graft and/or coil embolization). All patients received immunosuppressive therapy (prednisolone 60 mg/d) before endovascular therapy to induce remission. From February 1993 to January 2007, 8 arterial aneurysms in 7 patients (all men; mean age 33.0±7.9 years, range 25-51) were treated with surgical graft interposition over 31.5±23.2 months. Results: The endovascular procedure was successful in all lesions. The mean follow-up was 47.6±41.8 months, during which 4 complications in 3 patients (3/16, 18.8%) occurred (2 occluded stent-grafts and 2 access site pseudoaneurysm). There were no deaths. The cumulative primary patency rate in the endovascular group was 89% at 24 months. In the 7 patients undergoing graft interposition for 8 arterial aneurysms, 3 (42.9%) events occurred in follow-up: 2 recurrent pseudoaneurysms and 1 aneurysm-related death. Conclusion: In Behçet disease, aneurysm treatment is performed whenever possible because of the high risk of rupture. Endovascular treatment of arterial aneurysms was effective and safe, with an acceptable vascular complication rate and excellent patency of the treated site.

UR - http://www.scopus.com/inward/record.url?scp=71949107555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949107555&partnerID=8YFLogxK

U2 - 10.1583/09-2812.1

DO - 10.1583/09-2812.1

M3 - Article

C2 - 19842735

AN - SCOPUS:71949107555

VL - 16

SP - 631

EP - 636

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 5

ER -